Safety and efficacy of the next generation Resolute Onyx zotarolimus-eluting stent: Primary outcome of the RESOLUTE ONYX core trial
Catheterization and Cardiovascular Interventions Sep 28, 2017
Price MJ, et al. - This study examined the safety and efficacy of the novel Resolute (R-) Onyx drug-eluting stent (DES). Findings demonstrated that with the thin-strut novel composite wire R-Onyx DES versus Resolute DES, in-stent late lumen loss was non-inferior, and appeared to be superior.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
